Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
The Trade Desk Inc. (TTD) Appoints Andy Cunningham to its Board
-
Commercial Metals (CMC) Appoints John R. McPherson to its Board
-
Genius Brands Int'l (GNUS) Announces Launch of "Kartoon Channel! Kidaverse" Following Acquisition of Ameba TV
-
Akoya (AKYA) Announces Commercial Launch of PhenoCycler-Fusion
-
Forma Therapeutics Holdings (FMTX) Appoints Arturo Molina to its Board
-
Meta Platforms (FB) Appoints Tony Xu to its Board
-
ModivCare Inc. (MODV) Re-organized In-Home Services into Modivcare Home
-
Adamis Pharmaceuticals (ADMP) Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
-
Corsair Gaming (CRSR) Appoints Thi La and Sarah Mears Kim to its Board
-
RxSight (RXST) Appoints Tamara R. Fountain Shweta Singh Maniar and to its Board
-
KKR & Co. (KKR) Appoints Matthew Cohler as New Independent Director
-
Silicon Labs (SLAB) Appoints Sherri Luther to its Board
-
IES Holdings (IESC) Appoints Jennifer A. Baldock to its Board
-
Aditx Therapeutics Inc. (ADTX) Announces Amendment to Extend Worldwide Licensing Agreement, Granting Exclusivity in all Fields of Use
-
Wex, Inc. (WEX) Expands Global Executive Leadership Team with Two Appointments in Newly Created Roles
-
Coca Cola (KO) Appoints Herbert A. Allen III to its Board
-
SJW Group (SJW) Appoints Rebecca Armendariz Klein to its Board
-
CohBar (CWBR) Announces Board Changes, New R&D Leadership Appointments
-
Academy Sports and Outdoor (ASO) Appoints Chris Turner to its Board
-
Alpine Immune Sciences (ALPN) and Horizon Therapeutics (HZNP) Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases
-
Calliditas Therapeutics (CALT) TARPEYO Granted FDA Approval
-
SkyWater Technology (SKYT) Appoints Nancy Fares and Amy Leong to its Board
-
Kiora Pharmaceuticals (KPRX) Appoints David Hollander to its Board
-
Toll Brothers (TOL) Appoints Derek T. Kan to its Board
-
Duoling (DUOL) Names John Lilly to Board
-
Duoling (DUOL) Appoints John Lilly to its Board
-
Edwards Lifesciences (EW) sees 2022 adjusted earnings per share $2.50 - $2.65
-
Stanford Health Care Named Top Teaching Hospital by Leapfrog Group
-
Petco Health and Wellness (WOOF) Appoints Iris Yen as Board Advisor and Observer
-
Advance Technologies Inc (AVTX) Appoints June Almenoff and Mitchell Chan to its Board
-
Lyft (LYFT) Appoints Elaine Paul as CFO
-
C3.ai (AI) Reports Q2 Revenues of $58.3M, Non-GAAP EPS of $(0.23)
-
Vertex Pharma (VRTX) Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal Segmental Glomerulosclerosis
-
23andMe Holding Co. (ME) Appoints Joseph R. Arron as Chief Scientific Officer
-
Cybin Inc (CYBN) Announces FDA Approves a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress
-
Stanford University Partners with Kheiron Medical Technologies to Pioneer Use of AI in New Areas of Oncology
-
Krystal Biotech (KRYS) Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK in Patients with Dystrophic Epidermolysis Bullosa
-
ResMed (RMD) Appoints Desney Tan and John Hernandez to Its Board
-
Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by Vaxart
-
Sarepta Therapeutics (SRPT) Appoints Stephen L. Mayo to its Board
-
Taylor Morrison Home (TMHC) Appoints Christopher Yip to its Board
-
Kala Pharmaceuticals (KALA) Acquires Combangio
-
Talkspace (TALK) Awarded $3 Million Federal Grant to Study Groundbreaking Treatment for PTSD
-
Urban Affairs Coalition Announces Service Award Honorees in Celebration of 52 Years of Positive Community Impact
-
Heritage Financial (HFWA) Appoints Trevor Dryer and Gail Giacobbe to its Board
-
Myovant Sciences (MYOV) Appoints Nancy Valente to its Board
-
Omeros (OMER) Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial
-
Cognex Corp (CGNX) Appoints Marjorie T. Sennett to its Board
-
OneSpaWorld (OSW) and F45 Training (FXLV) Bring First F45 Studio on Board Celebrity Cruises
-
Quoin Pharmaceuticals Ltd (QNRX) Appoints Gordon Dunn as CFO

